Nilanjan Sengupta Selected Research

Nilanjan Sengupta Research Topics

Disease

6	Type 2 Diabetes Mellitus (MODY) 06/2021 - 03/2002
2	Neoplasms (Cancer) 02/2022 - 09/2004
2	Virilism (Virilization) 02/2022 - 01/2022
2	Precocious Puberty 02/2022 - 06/2016
2	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 02/2022 - 01/2022
2	Diabetes Mellitus 06/2021 - 07/2017
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2021 - 07/2017
2	Body Weight (Weight, Body) 03/2016 - 01/2014
2	Insulin Resistance 12/2012 - 03/2002
1	Disorders of Sex Development (Intersexuality) 02/2022
1	Granulosa cell tumor of the ovary 02/2022
1	Vitamin D Deficiency 02/2022
1	Albuminuria 12/2020
1	Chronic Renal Insufficiency 12/2020
1	Hyperglycemia 12/2020
1	Inflammation (Inflammations) 12/2020
1	Kidney Diseases (Kidney Disease) 12/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2020
1	Breast Neoplasms (Breast Cancer) 10/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 09/2016
1	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 09/2016
1	Hypogonadism (Hypergonadotropic Hypogonadism) 07/2015
1	Cushing Syndrome 07/2015
1	Osteoporosis 07/2015
1	Hypophosphatemia 10/2013
1	Hypercalcemia (Milk Alkali Syndrome) 10/2013
1	Chronic Thyroiditis 01/2013
1	Hemoglobinopathies 12/2012
1	Obesity 12/2012
1	Pheochromocytoma 12/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2012
1	HIV-Associated Lipodystrophy Syndrome 12/2012
1	Acromegaly 05/2012
1	Hyponatremia 03/2012
1	Inappropriate ADH Syndrome (SIADH) 03/2012
1	Genomic Instability 07/2007
1	Nijmegen Breakage Syndrome 07/2007
1	Carcinogenesis 07/2006
1	Weight Gain 03/2002

Drug/Important Bio-Agent (IBA)

3	Insulin (Novolin)FDA Link 06/2021 - 05/2012
3	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 12/2012
3	Metformin (Glucophage)FDA LinkGeneric 09/2016 - 03/2002
2	Insulin Glargine (Lantus)FDA Link 06/2021 - 07/2017
2	Folic Acid (Vitamin M)FDA LinkGeneric 09/2016 - 12/2012
2	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 09/2016 - 12/2012
1	Triptorelin Pamoate (Trelstar)FDA Link 02/2022
1	Aromatase (CYP19)IBA 02/2022
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 02/2022
1	17-alpha-Hydroxyprogesterone (17 Hydroxyprogesterone)IBA 02/2022
1	EnzymesIBA 02/2022
1	Adrenocorticotropic Hormone (ACTH)FDA Link 02/2022
1	Tumor Biomarkers (Tumor Markers)IBA 02/2022
1	AndrogensIBA 02/2022
1	hydroxide ionIBA 02/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2022
1	SaltsIBA 01/2022
1	3-Hydroxysteroid Dehydrogenases (3 beta Hydroxysteroid Dehydrogenase)IBA 01/2022
1	Biosimilar PharmaceuticalsIBA 06/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 06/2021
1	MYL-1501DIBA 06/2021
1	Sodium-Glucose Transport ProteinsIBA 12/2020
1	dapagliflozinIBA 12/2020
1	Monoclonal AntibodiesIBA 10/2018
1	Trastuzumab (Herceptin)FDA Link 10/2018
1	Oncogene Proteins (Oncogene Protein)IBA 10/2018
1	human ERBB2 proteinIBA 10/2018
1	HomocysteineIBA 09/2016
1	Pharmaceutical PreparationsIBA 09/2016
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 06/2016
1	GonadotropinsIBA 06/2016
1	Testosterone (Sustanon)FDA Link 06/2016
1	oxidized low density lipoproteinIBA 03/2016
1	SteroidsIBA 07/2015
1	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 07/2015
1	Bromocriptine (Parlodel)FDA LinkGeneric 01/2014
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2014
1	Insulin Detemir (Levemir)FDA Link 11/2013
1	Biphasic InsulinsIBA 11/2013
1	Insulin Aspart (NovoLog)FDA Link 11/2013
1	Parathyroid Hormone (Parathormone)IBA 10/2013
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2013
1	AntibodiesIBA 01/2013
1	IronIBA 12/2012
1	LipidsIBA 12/2012
1	MetanephrineIBA 12/2012
1	NormetanephrineIBA 12/2012
1	LeptinIBA 12/2012
1	Growth Hormone (Somatotropin)IBA 05/2012
1	ElectrolytesIBA 03/2012
1	Vasopressins (Vasopressin)IBA 03/2012
1	Sirtuin 1IBA 07/2007
1	Proteins (Proteins, Gene)FDA Link 07/2007
1	Telomerase (Telomerase Reverse Transcriptase)IBA 07/2006
1	Histone Deacetylase InhibitorsIBA 09/2004
1	CarbohydratesIBA 03/2002

Therapy/Procedure

5	Therapeutics 10/2018 - 03/2002
1	Transplantation 12/2020
1	Adrenalectomy 12/2012
1	Drug Therapy (Chemotherapy) 03/2002